3-(2-butyl-1-(2-diethylaminoethyl)-1H-benzoimidazol-5-yl)-N-hydroxyacrylamide-hydrochloride,
pracinostat,
SB939 compound,
Pracinostat,
929016-96-6,
SB939,
SB 939,
Pracinostat (SB939),
SB-939,
UNII-GPO2JN4UON,
GPO2JN4UON,
CHEMBL1851943,
(E)-3-(2-butyl-1-(2-(diethylamino)ethyl)-1H-benzo[d]imidazol-5-yl)-N-hydroxyacrylamide,
2-Propenamide, 3-[2-butyl-1-[2-(diethylamino)ethyl]-1H-benzimidazol-5-yl]-N-hydroxy-, (2E)-,
Pracinostat [INN],
(2E)-3-(2-Butyl-1-[2-(diethylamino)ethyl]-1h-1,3-benzodiazol-5-yl)-n-hydroxyprop-2-enamide,
(2E)-3-{2-butyl-1-[2-(diethylamino)ethyl]-1H-1,3-benzodiazol-5-yl}-N-hydroxyprop-2-enamide,
2-Propenamide, 3-(2-butyl-1-(2-(diethylamino)ethyl)-1H-benzimidazol-5-yl)-N-hydroxy-, (2E)-,
SB939,Pracinostat,
Pracinostat(SB939),
SB939 (Pracinostat),
cc-70,
MLS006011217,
SCHEMBL833105,
GTPL8365,
CHEBI:95071,
DTXSID00239196,
EX-A351,
AOB87709,
BCP02073,
ABP000582,
BDBM50105330,
MFCD17215206,
s1515,
SB 939SB-939,
ZINC43152558,
AKOS027250824,
SB-939, SB939,
CS-0567,
DB05223,
RL05848,
SB16668,
NCGC00263136-04,
AS-19395,
BC660004,
HY-13322,
QC-10486,
SC-86253,
SMR004702979,
AB0008159,
SW219429-1,
X7533,
EC-000.2481,
W-5687,
(2E)-3-[2-Butyl-1-[2-(diethylaMino)ethyl]-1H-benziMidazol-5-yl]-N-hydroxy-2-propenaMide,
(2E)-3-{2-butyl-1-[2-(diethylamino)ethyl]-1,3-benzodiazol-5-yl}-N-hydroxyprop-2-enamide,
(E)-3-[2-butyl-1-(2-diethylaminoethyl)benzimidazol-5-yl]prop-2-enehydroxamic acid,
SB939 compound,
D0L2UQ,
Ganetespib (STA-9090),
C20H30N4O2,
ACN-029579,
A4095,
A10830,
C557525,
3-(2-butyl-1-(2-diethylaminoethyl)-1H-benzoimidazol-5-yl)-N-hydroxyacrylamide-hydrochloride,